The Effect of Isotretinoin-Induced Myalgia on Daily Quality of Life and Evaluation of Serum Creatine Phosphokinase Levels

INTRODUCTION: The aim of this study was to evaluate the effect of the myalgia observed as a side effect of isotretinoin used for severe and treatment-resistant moderate acne on patient quality of life and to investigate the relationship between serum creatine phosphokinase (CPK) levels and myalgia i...

Full description

Bibliographic Details
Main Author: Ebru Karagun
Format: Article
Language:English
Published: Van Yuzuncu Yil University, School of Medicine 2019-10-01
Series:Van Tıp Dergisi
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-26918
_version_ 1797425247328141312
author Ebru Karagun
author_facet Ebru Karagun
author_sort Ebru Karagun
collection DOAJ
description INTRODUCTION: The aim of this study was to evaluate the effect of the myalgia observed as a side effect of isotretinoin used for severe and treatment-resistant moderate acne on patient quality of life and to investigate the relationship between serum creatine phosphokinase (CPK) levels and myalgia in these patients. METHODS: Included in the study were 216 patients between the ages of 15 and 40 presenting to the outpatient clinic. During isotretinoin treatment, the effect of muscle pain on the daily quality of life of patients with myalgia was evaluated according to the myalgia severity level (0: N/A; 1: Significant in the morning but not preventing normal activity during the day; 2: Affecting normal activity during the day; 3: Preventing normal daily activities). CPK levels of patients included in the study were screened retrospectively from their files. RESULTS: Of the 216 patients included in the study, 124 were female, 92 were male and the mean age was 24+-5.3. Myalgia was detected in 48% of the patients (n: 104). Of the patients diagnosed with myalgia, 61.5% (n: 64) were classified as 1, 32.6% (n: 34) as 2 and 5.7% as 3. Serum CPK levels were elevated in 30.7% (n: 32) of the 104 myalgia patients. DISCUSSION AND CONCLUSION: Myalgia is a common side effect that can be seen in nearly half of patients during isotretinoin use. It was determined that the myalgia observed during isotretinoin use was at a tolerable level and had nosignificant effect on the daily quality of life. Although no correlation was found between myalgia and serum CPK levels.
first_indexed 2024-03-09T08:13:17Z
format Article
id doaj.art-1fff0a959d57485d9bcfaf9f5f85f456
institution Directory Open Access Journal
issn 2587-0351
language English
last_indexed 2024-03-09T08:13:17Z
publishDate 2019-10-01
publisher Van Yuzuncu Yil University, School of Medicine
record_format Article
series Van Tıp Dergisi
spelling doaj.art-1fff0a959d57485d9bcfaf9f5f85f4562023-12-02T22:48:30ZengVan Yuzuncu Yil University, School of MedicineVan Tıp Dergisi2587-03512019-10-0126445245510.5505/vtd.2019.26918VTD-26918The Effect of Isotretinoin-Induced Myalgia on Daily Quality of Life and Evaluation of Serum Creatine Phosphokinase LevelsEbru Karagun0Duzce University Faculty of Medicine, Dermatology Department, DuzceINTRODUCTION: The aim of this study was to evaluate the effect of the myalgia observed as a side effect of isotretinoin used for severe and treatment-resistant moderate acne on patient quality of life and to investigate the relationship between serum creatine phosphokinase (CPK) levels and myalgia in these patients. METHODS: Included in the study were 216 patients between the ages of 15 and 40 presenting to the outpatient clinic. During isotretinoin treatment, the effect of muscle pain on the daily quality of life of patients with myalgia was evaluated according to the myalgia severity level (0: N/A; 1: Significant in the morning but not preventing normal activity during the day; 2: Affecting normal activity during the day; 3: Preventing normal daily activities). CPK levels of patients included in the study were screened retrospectively from their files. RESULTS: Of the 216 patients included in the study, 124 were female, 92 were male and the mean age was 24+-5.3. Myalgia was detected in 48% of the patients (n: 104). Of the patients diagnosed with myalgia, 61.5% (n: 64) were classified as 1, 32.6% (n: 34) as 2 and 5.7% as 3. Serum CPK levels were elevated in 30.7% (n: 32) of the 104 myalgia patients. DISCUSSION AND CONCLUSION: Myalgia is a common side effect that can be seen in nearly half of patients during isotretinoin use. It was determined that the myalgia observed during isotretinoin use was at a tolerable level and had nosignificant effect on the daily quality of life. Although no correlation was found between myalgia and serum CPK levels.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-26918isotretinoinmyalgiacreatine kinase
spellingShingle Ebru Karagun
The Effect of Isotretinoin-Induced Myalgia on Daily Quality of Life and Evaluation of Serum Creatine Phosphokinase Levels
Van Tıp Dergisi
isotretinoin
myalgia
creatine kinase
title The Effect of Isotretinoin-Induced Myalgia on Daily Quality of Life and Evaluation of Serum Creatine Phosphokinase Levels
title_full The Effect of Isotretinoin-Induced Myalgia on Daily Quality of Life and Evaluation of Serum Creatine Phosphokinase Levels
title_fullStr The Effect of Isotretinoin-Induced Myalgia on Daily Quality of Life and Evaluation of Serum Creatine Phosphokinase Levels
title_full_unstemmed The Effect of Isotretinoin-Induced Myalgia on Daily Quality of Life and Evaluation of Serum Creatine Phosphokinase Levels
title_short The Effect of Isotretinoin-Induced Myalgia on Daily Quality of Life and Evaluation of Serum Creatine Phosphokinase Levels
title_sort effect of isotretinoin induced myalgia on daily quality of life and evaluation of serum creatine phosphokinase levels
topic isotretinoin
myalgia
creatine kinase
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-26918
work_keys_str_mv AT ebrukaragun theeffectofisotretinoininducedmyalgiaondailyqualityoflifeandevaluationofserumcreatinephosphokinaselevels
AT ebrukaragun effectofisotretinoininducedmyalgiaondailyqualityoflifeandevaluationofserumcreatinephosphokinaselevels